Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.46 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.41 |
| ▸ | TUBB | P07437 | 3/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221032 | 1.00 | FDPS (0.46) | FDPSTUBB1MAPTSMN1; SMN2LMNA | |
| SCHEMBL222288 | 1.00 | FDPS (0.46) | FDPSTUBB1MAPTSMN1; SMN2LMNA | |
| SCHEMBL29521713 | 1.00 | FDPS (0.46) | FDPSTUBB1MAPTSMN1; SMN2LMNA | |
| SCHEMBL2564332 | 0.85 | ALDH1A1 (0.56) | FDPSSMN1; SMN2HTTALDH1A1HPGD | |
| SCHEMBL2564338 | 0.85 | ALDH1A1 (0.56) | FDPSSMN1; SMN2HTTALDH1A1HPGD | |
| SCHEMBL2564336 | 0.85 | ALDH1A1 (0.56) | FDPSSMN1; SMN2HTTALDH1A1HPGD | |
| SCHEMBL2848457 | 0.82 | TUBB1 (0.49) | FDPSTUBB1MAPTSMN1; SMN2LMNA | |
| SCHEMBL221117 | 0.82 | TUBB1 (0.49) | FDPSTUBB1MAPTSMN1; SMN2LMNA | |
| SCHEMBL1006237 | 0.81 | CYP2C9 (0.45) | FDPSTUBB1MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL1006239 | 0.81 | CYP2C9 (0.45) | FDPSTUBB1MAPTSMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088955-B2 | Alpha-substituted α,β-unsaturated E- or Z-aldehydes, use thereof, and processes for their preparation α,β | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG (AT) | 2012-01-03 | — | — | US | claimed |
| US-20100234630-A1 | ALPHA-SUBSTITUTED A,B-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION A,B | DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) | 2010-09-16 | — | — | US | claimed |
| EP-2178816-A1 | ALPHA-SUBSTITUTED , -UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION , | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2010-04-28 | — | — | EP | claimed |
| WO-2009007462-A1 | ALPHA-SUBSTITUTED α,β-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION α,β | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG (AT) | 2009-01-15 | — | — | WO | claimed |
| US-20130252288-A1 | ENANTIOSELECTIVE REDUCTION | DSM IP ASSETS B.V. (NL) | 2013-09-26 | — | — | US | disclosed |
| US-8088955-B2 | Alpha-substituted α,β-unsaturated E- or Z-aldehydes, use thereof, and processes for their preparation α,β | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG (AT) | 2012-01-03 | — | — | US | disclosed |
| US-20110301365-A1 | ALPHA-SUBSTITUTED ALPHA, BETA-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION ALPHA, BETA | DSM IP ASSETS B.V. (NL) | 2011-12-08 | — | — | US | disclosed |
| EP-2275398-A1 | APPLICATION OF THE IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION FOR UNSATURATED CARBOXYLIC ACID | Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) | 2011-01-19 | — | — | EP | disclosed |
| US-20100234630-A1 | ALPHA-SUBSTITUTED A,B-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION A,B | DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG (AT) | 2010-09-16 | — | — | US | disclosed |
| EP-2178816-A1 | ALPHA-SUBSTITUTED , -UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION , | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2010-04-28 | — | — | EP | disclosed |
| EP-2171077-A2 | ENANTIOSELECTIVE REDUCTION | DSM IP Assets B.V. (NL) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009007462-A1 | ALPHA-SUBSTITUTED α,β-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION α,β | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG (AT) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009007460-A2 | ENANTIOSELECTIVE REDUCTION | DSM IP ASSETS B.V. (NL) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301365-A1 | ALPHA-SUBSTITUTED ALPHA, BETA-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION ALPHA, BETA | CYP8B1, ECH1, NR1H2 | FDPS 310/4885TUBB1 1017/4885MAPT 3984/4885 |
| US-20100234630-A1 | ALPHA-SUBSTITUTED A,B-UNSATURATED E- OR Z-ALDEHYDES, USE THEREOF, AND PROCESSES FOR THEIR PREPARATION A,B | CYP8B1, CYP1B1, ADRA1A | FDPS 265/4885TUBB1 1386/4885MAPT 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.